How to suspect tularemia in a child outside the endemic focus

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Tularemia is an acute zoonotic natural focal disease caused by Francisella tularensis, with a variety of pathogen transmission mechanisms. A person becomes infected in various ways, mainly through insect bites (mosquitoes, ticks), through direct contact with infected animals, and also by inhalation. The disease is characterized by high fever, intoxication, inflammatory changes in the area of the entrance gate, regional lymphadenitis. It is often difficult to suspect tularemia in the early stages due to the lack of specificity of clinical manifestations (fever, intoxication, regional lymphadenitis). Even in endemic regions, in most cases, acute respiratory viral infection, lymphadenitis, fever of unknown origin are diagnosed, which leads to a late start of etiotropic treatment. There is a clinical case of tularemia in a 13-year-old child who was misdiagnosed in the early stages of the disease. And only a careful collection of an epidemiological history (stay in an endemic area, a mosquito bite), as well as a competent assessment of clinical and laboratory data, allowed tularemia to be included in the differential diagnosis on the 18th day of the disease and confirmed by the detection of the highest titers of anti-tularemia antibodies in blood serum. Thus, against the background of low morbidity, especially in childhood, there is no alertness among doctors of all specialties, which leads to late diagnosis and, as a consequence, late started specific treatment. All children with prolonged fever in the presence of lymphadenitis of unknown genesis, who have been in a territory unfavorable for tularemia, need to undergo a specific examination to identify mild and erased forms of the disease.

Full Text

Restricted Access

About the authors

Vladimir N. Timchenko

St. Petersburg State Pediatric Medical University

Author for correspondence.
Email: timchenko22081953@yandex.ru

MD, PhD, Dr. Med. Sci., Professor, Head, Department of infectious Diseases in Children named after Professor M.G.Danilevich

Russian Federation, Saint Petersburg

Elena V. Barakina

St. Petersburg State Pediatric Medical University

Email: elenabarakina@mail.ru

MD, PhD, Assistant, Department of Infectious Diseases in Children named after Professor M.G. Danilevich

Russian Federation, Saint Petersburg

Tatyana M. Chernova

St. Petersburg State Pediatric Medical University

Email: detinfection@mail.ru

MD, PhD, Associate Professor, Department of Infectious Diseases in Children named after Professor M.G. Danilevich

Russian Federation, Saint Petersburg

Oksana V. Bulina

St. Petersburg State Pediatric Medical University

Email: detinfection@mail.ru

MD, PhD, Associate Professor, Department of Rehabilitation FP and DPO

Russian Federation, Saint Petersburg

Olga O. Fedyuchek

Children’s Polyclinic No. 30

Email: detinfection@mail.ru

infectious disease doctor

Russian Federation, Saint Petersburg

Lyubov M. Pochinyaeva

Children’s City Clinical Hospital No. 5 named after N.F. Filatov

Email: detinfection@mail.ru

doctor, Deputy Chief Physician for the Medical Part

Russian Federation, Saint Petersburg

Marina Y. Koshchavtseva

Children’s City Clinical Hospital No. 22

Email: detinfection@mail.ru

doctor of the highest category, Head of the Infectious-Boxed Department

Russian Federation, Saint Petersburg

Natalya V. Shvedovchenko

Children’s City Clinical Hospital No. 22

Email: detinfection@mail.ru

doctor of the Infectious-Boxing Department

Russian Federation, Saint Petersburg

References

  1. Infekcionnye bolezni u detej. Uchebnik 4-е izd. Timchenko VN. editor. Saint Petersburg; 2012. P. 526–533. (In Russ.)
  2. Klinicheskie rekomendacii po diagnostike limfadenopatij. Nacional’noe gematologicheskoe obshhestvo. 2014. 38 р. (In Russ.) Available from: https://blood.ru/documents/clinical%20guidelines/13.%20klinicheskie-rekomendacii-2014-lap.pdf
  3. Meshherjakova IS, Dobrovol’skij AA, Demidova TN, et al. Transmissible epidemic outbreak of tularemia in Khanty-Mansiysk in 2013. Epidemiology and Vaccine Prevention. 2014;(5):14–20. (In Russ.)
  4. O sostojanii sanitarno-jepidemiologicheskogo blagopoluchija naselenija v Rossijskoj Federacii v 2019 godu: Gosudarstvennyj doklad / Federal’naja sluzhba po nadzoru v sfere zashhity prav potrebitelej i blagopoluchija cheloveka. Moscow; 2020. 299 р. (In Russ.) Available from: https://www.rospotrebnadzor.ru/documents/details.php? ELEMENT_ID=14933
  5. O sostojanii sanitarno-jepidemiologicheskogo blagopoluchija naselenija v Respublike Karelija v 2019 godu: Gosudarstvennyj doklad / Upravlenie Federal’noj sluzhby po nadzoru v sfere zashhity prav potrebitelej i blagopoluchija cheloveka po Respublike Karelija. Petrozavodsk; 2020. 173 р. (In Russ.)
  6. Syrova NA, Tereshkina NE, Devdariani ZL. Current State of Tularemia Immunodiagnostics. Problems of Particularly Dangerous Infections. 2008;(3):12–15. (In Russ.) doi: 10.21055/0370-1069-2008-3(97)-12-15
  7. Tuljaremija. Upravlenie Rospotrebnadzora po respublike Marij Jel. Jepidemiologicheskij nadzor. Available from: http://12.rospotrebnadzor.ru/bytag2/-/asset_publisher/x85V/content/туляремия. (In Russ.)
  8. Antonitsch L, Weidinger G, Stanek G, et al. Francisella tularensis as the cause of protracted fever. BMC Infectious Diseases. 2020;20(1):327. doi: 10.1186/s12879-020-05051-1
  9. Balestra A, Bytyci H, Guillod C, et al. A case of ulceroglandular tularemia presenting with lymphadenopathy and an ulcer on a linear morphoea lesion surrounded by erysipelas. International Medical Case Reports Journal. 2018;11:313–318. doi: 10.2147/IMCRJ.S178561
  10. Caspar Yv, Maurin M. Francisella tularensis Susceptibility to Antibiotics: A Comprehensive Review of the Data Obtained In vitro and in Animal Models. Front Cell Infect Microbiol. 2017;7:122. doi: 10.3389/fcimb.2017.00122
  11. Claviez A, Behrends U, Grundmann T, et al. Lymphknotenvergrößerung. Die Leitlinie (Fünfte Fassung). AWMFonline: 2020. Available from: https://www.awmf.org/leitlinien/detail/ll/025-020.html (In German)
  12. Darmon-Curti A, Darmon F, Edouard S et al. Tularemia: A Case Series of Patients Diagnosed at the National Reference Center for Rickettsioses From 2008 to 2017. Open Forum Infectious Diseases. 2020;7(11):ofaa440. doi: 10.1093/ofid/ofaa440
  13. Hestvik G, Warns-Petit E, Smith A.L, et al. The status of tularemia in Europe in a one-health context: A review. Epidemiology and Infection. 2014;143(10):137–160. doi: 10.1017/S0950268814002398
  14. Lang S, Kansy B. Cervical lymph node diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014;13: Doc08. doi: 10.3205/cto000111
  15. Mani Rinosh J, Morton Rebecca J, Kenneth D. Ecology of Tularemia in Central US Endemic Region. Current Tropical Medicine Reports. 2016;3:75–79. doi: 10.1007/s40475-016-0075-1

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure. Results of ultrasound examination of the inguinal lymph nodes of a 13-year-old child with tularemia: а – enlarged lymph node with clear edges, heterogeneous structure of the parenchyma with hyper- and hypoechoic inclusions; b – not increased, the structure of the parenchyma and surrounding tissues is not changed

Download (114KB)

Copyright (c) 2021 Timchenko V.N., Barakina E.V., Chernova T.M., Bulina O.V., Fedyuchek O.O., Pochinyaeva L.M., Koshchavtseva M.Y., Shvedovchenko N.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies